In a regulatory filing, Abbott disclosed that its director Daniel Starks sold 50K shares of common stock on October 26th in a total transaction size of $4.70M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ABT:
- Abbott (NYSE:ABT) Up Fractionally despite FDA Warning Letter
- Abbott announces late-breaking data from LIFE-BTK clinical trial
- Abbott reports data from trials of its heart devices to treat valve diseases
- Abbott price target lowered to $110 from $123 at Raymond James
- Abbott price target raised to $122 from $118 at UBS